Steve is a brand marketing and product management expert with over 25 years of experience. He’s worked in a myriad of vertical industries with enabling technologies including anti-counterfeiting, supply chain and product lifecycle management. As a thought leader, Steve has written several white papers and is a frequent contributor of content to global industry publications across pharmaceutical and consumer packaged goods industries. His specialty areas include supply chain security, traceability, blockchain and brand/consumer protection.
David is a senior manager focused on product security at Johnson & Johnson based in Raritan, New Jersey. His role involves protecting J&J brands from illicit activity and working to enhance supply chain security. David has been with the company for 12 years and is currently developing new innovative strategies that center on disruptive technology and putting the customer first. He works to deliver high-value digital solutions that solve business problems and drive growth for J&J.
Dr. Mark Willis
Willis QS Consulting
Mark is a seasoned pharmaceuticals and medical device professional with more than 20 years’ experience in the industry. He has experience leading global regulatory programs as both a project manager (PMP) and as a software quality engineer participant (certified SQE and Quality Auditor). With a doctorate in law and public policy, as well as a participant in the construction of the recent ISO 9001 update, Mark has provided consultation on how to “right size” an organization's regulatory compliance so that its software implementations are able to meet its needs without distracting from daily operations. As a professor at Northeastern University, Bunker Hill College, and Massachusetts College of Pharmacy and Health Sciences (MCPHS), Mark currently works with global health authority agencies, as well as the UN and USAID to conduct research for technological solutions such as Blockchain and PCIDs to secure the pharmaceutical supply chain and is the author of Counterfeit Pharmaceuticals: Are the U.S. Consumers Aware of the Potential Risks?
Originally aired 2/27/20.